Human leukocyte antigen DR alpha inhibits renal cell carcinoma progression by promoting the polarization of M2 macrophages to M1 via the NF-κB pathway
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2024.113706 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Feng Xiong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Urology Surgery Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: 15504627313@163.com. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, NF-kappa B, Signal Transduction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Human leukocyte antigen DR alpha (HLA-DRA) is recognized for its inhibitory effect on the progression of clear cell renal cell carcinoma (ccRCC); high HLA-DRA expression levels are positively correlated with improved prognosis in patients with ccRCC. In this study, we evaluated HLA-DRA expression in ccRCCs, its effects on tumor-associated macrophage recruitment, and the influence of polarization. Clinical cohort analyses revealed that elevated HLA-DRA expression in ccRCC cells was correlated with enhanced tumor infiltration by M1-type macrophages. In addition, ccRCC prognosis was predicted by combining HLA-DRA expression level analysis and the M1/M2 macrophage ratio. In vitro studies demonstrated that ccRCC cells with increased HLA-DRA expression promoted THP-1 cell migration and induced macrophage polarization toward the M1 phenotype. The effect was further substantiated in a mouse xenograft model in which an increase in M1 macrophages was observed. In addition, co-culturing macrophages with the supernatant from cells overexpressing HLA-DRA induced the expression of proteins associated with both M1 and M2 macrophage polarization. HLA-DRA was intricately linked to the expression and secretion of chemokines, including CCL2, CCL5, MIP-1ɑ, and CXCL-10. Moreover, the NF-κB pathway activation promoted polarization to M1 macrophages. This study shows that HLA-DRA and the M1/M2 ratio are indicators of favorable prognosis in patients with ccRCC. HLA-DRA promotes M1-like polarization by regulating NF-κB, which can be used as a therapeutic target to enhance anti-tumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urology Surgery Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: 15504627313@163.com.
- Urology Surgery Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: wangbowen@hrbmu.edu.cn.
- Urology Surgery Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: doczhanghaoxun@163.com.
- Urology Surgery Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: guoling_zhang@163.com.
- Urology Surgery Department, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China. Electronic address: 707885664@qq.com.
- Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin 150081, China. Electronic address: liu_yujie1011@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xiong, F., Wang, B., Zhang, H., Zhang, G., Liu, Y., Liu, Y., & Wang, C. (2025). Human leukocyte antigen DR alpha inhibits renal cell carcinoma progression by promoting the polarization of M2 macrophages to M1 via the NF-κB pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113706
Vancouver
Xiong F, Wang B, Zhang H, Zhang G, Liu Y, Liu Y, et al. Human leukocyte antigen DR alpha inhibits renal cell carcinoma progression by promoting the polarization of M2 macrophages to M1 via the NF-κB pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2024.113706
BibTeX
@article{Xiong2025,
author = {Xiong, Feng and Wang, Bowen and Zhang, Haoxun and Zhang, Guoling and Liu, Yiwen and Liu, Yujie and Wang, Chunyang},
title = {Human leukocyte antigen DR alpha inhibits renal cell carcinoma progression by promoting the polarization of M2 macrophages to M1 via the NF-κB pathway},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2024.113706}
}
EUVIMED